Over the last 12 months, Avanos Medical insiders reported no purchases and 9 sales totaling $33.8M across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Delgado SigfridoSVP, Operations · O | ▽ Sale to issuer | 110,627 | $25 | $2.8M | -100% | 2 tranches |
| Jul 27, 2026 | Galovan Scott MichaelSVP, Chief Financial Officer · O | ▽ Sale to issuer | 231,717 | $25 | $5.8M | -100% | 2 tranches |
| Jul 27, 2026 | Pacitti DavidChief Executive Officer · O | ▽ Sale to issuer | 766,924 | $25 | $19.2M | -100% | 2 tranches |
| Jul 27, 2026 | Shimer Julie AnnD | ▽ Sale to issuer | 50,090 | $25 | $1.3M | -100% | — |
| Jul 27, 2026 | OLEARY PATRICK JD | ▽ Sale to issuer | 54,640 | $25 | $1.4M | -100% | — |
| Jul 27, 2026 | Franchini Indrani LallD | ▽ Sale to issuer | 4,817 | $25 | $120K | -100% | — |
| Jul 27, 2026 | Egbuonu-Davis LisaD | ▽ Sale to issuer | 13,811 | $25 | $345K | -100% | — |
| Jul 27, 2026 | BLACKFORD GARYD | ▽ Sale to issuer | 79,590 | $25 | $2.0M | -100% | — |
| Jul 27, 2026 | BLACKFORD GARYD | ▽ Sale to issuer | 40,000 | $25 | $1.0M | -100% | indirect |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AVNS feed.